基于HRA模型的健康體檢人群腦卒中風(fēng)險(xiǎn)評(píng)估
[Abstract]:Objective: Stroke, also known as cerebrovascular accident or apoplexy, is an acute cerebrovascular disease characterized by cerebral blood flow disturbance caused by cerebral vascular obstruction or rupture and impairment of brain tissue function or structure. In order to curb the high incidence of stroke, China has launched the Stroke Screening and Prevention Project (CSSPP) in 2009, aiming to improve the awareness rate of stroke risk factors, control rate, reduce the incidence of stroke, recurrence rate, mortality and disability rate, thereby reducing the death rate of stroke in Chinese residents through the implementation of the project. The project screens people aged 40 years and over for eight major risk factors. Those with three or more risk factors can be classified as high-risk groups for stroke. The effectiveness of the screening strategy for high-risk groups is still unknown, and it only passes. Counting the number of risk factors does not take into account that each risk factor has a different impact on the incidence of stroke. To explore the strategy of screening high-risk population of stroke based on health risk assessment model (HRA), and to compare the results with the results of CSSPP screening, so as to provide the basis for optimizing the screening strategy of high-risk population of stroke in China. Methods: By searching CNKI knowledge network service platform, Wanfang database and PubMed database, collecting the published data from 1990 to 2015 at home and abroad. Literatures on eight risk factors for stroke in Chinese Han population (including hypertension, diabetes, heart disease, hyperlipidemia, family history of stroke, overweight, smoking and physical exercise) were evaluated by Nos scale. Literatures that met the inclusion criteria were included if the score was greater than 5. Reviewer manager 5.3 and Stata 12.0 analysis. Health Risk Assessment Model (HRA) screening strategy for high-risk population was based on meta-analysis of 8 risk factors for stroke, and combined with the incidence of stroke in each age group, the incidence of stroke in the next five years was calculated by mathematical model. Results: A total of 178 case-control studies and 15 cohort studies were included. Of the eight risk factors included in the screening strategy in China, hypertension was the most important independent risk factor for stroke. Factors (OR = 3.50, 95% CI: 3.18-3.85; RR = 2.68, 95% CI = 2.20-3.26); diabetes mellitus, heart disease, family history of stroke, hyperlipidemia, overweight and smoking were moderate risk factors for stroke. The combined ratio was between 1.82 and 2.68, and the combined risk was between 1.27 and 2.47; physical exercise was the insurance against stroke. Protective factors (OR = 0.49, 95% CI: 0.29-0.83), P values were all lower than 0.05. Subgroup analysis showed that hyperlipidemia was associated with ischemic stroke attack, but there was no significant correlation between hyperlipidemia and hemorrhagic stroke attack. The average 5-year stroke incidence rate in males was higher than that in females. The average 5-year stroke incidence rate increased with the number of risk factors. According to the CSSPP screening strategy, 918 (21.9%) high-risk individuals were screened. According to the HRA screening strategy, 219. The average incidence of stroke in humans exceeded the high-risk threshold (2.5%), but was judged as low-risk individuals by the screening strategy of CSSPP because the number of risk factors was less than three. However, 10.5% of the individuals identified as low-risk by the screening strategy of CSSPP had hypertension and 9.4% had diabetes. The results show that different risk factors have different effects on stroke onset. At present, the screening strategy for high-risk stroke patients who only count the number of risk factors without considering their correlation strength may reduce the effectiveness of screening. Considering the influence of various factors, the HRA model may improve the screening effect of stroke in combination with the CSSPP project screening strategy. It is worth noting that since hypertension and diabetes are independent risk factors for stroke, more measures should be taken to control individual blood pressure and glucose. It is hoped that this study will help to increase the risk of stroke. The cost effectiveness of crowd screening will help relevant institutions to take more effective intervention measures.
【學(xué)位授予單位】:天津醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R743.3
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 王傳玉,郭秀麗,張靜;腦卒中偏癱患者出院時(shí)的康復(fù)指導(dǎo)[J];現(xiàn)代康復(fù);2000年04期
2 池靜波,侯素萍;腦卒中偏癱患者的健康教育[J];臨床醫(yī)藥實(shí)踐;2003年08期
3 沈愛媛,葉凌華;腦卒中偏癱病人的健康教育[J];時(shí)珍國(guó)醫(yī)國(guó)藥;2003年11期
4 路偉,劉立明;康復(fù)鍛煉配合電針治療腦卒中偏癱48例療效觀察[J];山東醫(yī)藥;2004年20期
5 于艷馥,管艷,王艷輝;健康教育對(duì)提高腦卒中偏癱患者早期康復(fù)的意義[J];醫(yī)學(xué)理論與實(shí)踐;2005年05期
6 曾育山,陳其強(qiáng),唐月清;減重支持系統(tǒng)訓(xùn)練對(duì)腦卒中偏癱患者步態(tài)的影響[J];海南醫(yī)學(xué);2005年06期
7 王瑞平;;腦卒中偏癱患者強(qiáng)化作業(yè)治療30例報(bào)告[J];中國(guó)實(shí)用醫(yī)藥;2008年36期
8 何戎;;腦卒中偏癱患者的健康教育[J];求醫(yī)問藥(下半月);2012年08期
9 牟清華;吳紅霞;;腦卒中偏癱早期康復(fù)的護(hù)理方法[J];中國(guó)醫(yī)藥指南;2013年28期
10 朱瓊祥,李元生,羅榮先;早期康復(fù)在腦卒中偏癱治療中的應(yīng)用[J];臨床薈萃;2000年06期
相關(guān)會(huì)議論文 前10條
1 藺勇;劉世文;;腦卒中患者偏癱側(cè)肢體的神經(jīng)生理學(xué)研究[A];中國(guó)康復(fù)醫(yī)學(xué)會(huì)第四屆會(huì)員代表大會(huì)暨第三屆中國(guó)康復(fù)醫(yī)學(xué)學(xué)術(shù)大會(huì)論文匯編[C];2001年
2 黃松波;;腦卒中偏癱的恢復(fù)過程與預(yù)后[A];繼往開來 與時(shí)俱進(jìn)——2003年康復(fù)醫(yī)學(xué)發(fā)展論壇暨慶祝中國(guó)康復(fù)醫(yī)學(xué)會(huì)成立20周年學(xué)術(shù)大會(huì)論文集[C];2003年
3 金妹;朱美紅;陳嶠鸚;傅建明;李巖;;小組合作管理對(duì)康復(fù)期腦卒中患者預(yù)防跌倒的影響[A];中國(guó)康復(fù)醫(yī)學(xué)會(huì)第十四次腦血管病康復(fù)學(xué)術(shù)會(huì)議暨中華中醫(yī)藥學(xué)會(huì)第九次養(yǎng)生康復(fù)學(xué)術(shù)會(huì)議論文匯編[C];2011年
4 潘虹;;整體護(hù)理模式在腦卒中偏癱患者護(hù)理中的體現(xiàn)[A];2011年甘肅省中醫(yī)藥學(xué)會(huì)學(xué)術(shù)年會(huì)論文集[C];2011年
5 金妹;朱美紅;陳嶠鸚;傅建明;李巖;;小組合作管理對(duì)康復(fù)期腦卒中患者預(yù)防跌倒的影響[A];中國(guó)康復(fù)醫(yī)學(xué)會(huì)腦血管病專業(yè)委員會(huì)換屆暨第十五次全國(guó)腦血管病康復(fù)學(xué)術(shù)年會(huì)、湖南省康復(fù)醫(yī)學(xué)會(huì)神經(jīng)康復(fù)專業(yè)委員會(huì)2012學(xué)術(shù)年會(huì)論文集[C];2012年
6 魏玉華;;中西醫(yī)結(jié)合三級(jí)康復(fù)防治腦卒中偏癱的研究和實(shí)踐[A];第三屆泛中醫(yī)論壇·思考中醫(yī)2007——中醫(yī)“治未病”暨首屆扶陽(yáng)論壇論文集[C];2007年
7 張捧玉;荀鳳閣;周群拉;張偉;范愛國(guó);;腦卒中偏癱早期康復(fù)及維持性康復(fù)臨床研究[A];第三屆全國(guó)康復(fù)醫(yī)學(xué)青年學(xué)術(shù)會(huì)議論文集[C];1999年
8 李茜;;運(yùn)動(dòng)功能評(píng)價(jià)量表在腦卒中偏癱康復(fù)中的應(yīng)用研究[A];中國(guó)醫(yī)師協(xié)會(huì)第二屆康復(fù)醫(yī)學(xué)論壇、中國(guó)康復(fù)醫(yī)學(xué)會(huì)第四屆青年學(xué)術(shù)會(huì)議、北京康復(fù)醫(yī)學(xué)會(huì)第三屆會(huì)員代表大會(huì)論文集[C];2005年
9 李平仙;;指導(dǎo)腦卒中偏癱康復(fù)的進(jìn)展[A];全國(guó)內(nèi)科護(hù)理學(xué)術(shù)交流暨專題講座會(huì)議論文匯編[C];2005年
10 尤欣;;運(yùn)用護(hù)理程序?qū)δX卒中偏癱患者實(shí)施健康教育及康復(fù)指導(dǎo)[A];中國(guó)水利電力醫(yī)學(xué)科學(xué)技術(shù)學(xué)會(huì)臨床醫(yī)學(xué)專業(yè)委員會(huì)外科專業(yè)、護(hù)理專業(yè)2007年會(huì)論文匯編[C];2007年
相關(guān)重要報(bào)紙文章 前6條
1 本報(bào)記者 慕欣;遠(yuǎn)離腦卒中[N];醫(yī)藥經(jīng)濟(jì)報(bào);2009年
2 衣曉峰 吳力勇;腦卒中偏癱患者早期康復(fù)乃重中之重[N];中國(guó)中醫(yī)藥報(bào);2002年
3 ;疏筋利節(jié)法在腦卒中偏癱中的應(yīng)用[N];中國(guó)中醫(yī)藥報(bào);2004年
4 張春紅邋卞金玲;腦卒中后中樞性疼痛的綜合治療[N];中國(guó)中醫(yī)藥報(bào);2007年
5 張春紅;腦卒中后中樞性疼痛的綜合治療[N];農(nóng)村醫(yī)藥報(bào)(漢);2009年
6 天津中醫(yī)藥大學(xué)第一附屬醫(yī)院 張春紅 卞金玲;腦卒中后中樞性疼痛應(yīng)綜合治療[N];中國(guó)中醫(yī)藥報(bào);2008年
相關(guān)博士學(xué)位論文 前2條
1 岳偉;中國(guó)40歲及以上人群腦卒中患病率及相關(guān)危險(xiǎn)因素的調(diào)查研究[D];天津醫(yī)科大學(xué);2016年
2 李貞蘭;強(qiáng)制性使用運(yùn)動(dòng)療法在恢復(fù)期腦卒中偏癱的行為學(xué)作用研究[D];吉林大學(xué);2008年
相關(guān)碩士學(xué)位論文 前10條
1 王晶;基于HRA模型的健康體檢人群腦卒中風(fēng)險(xiǎn)評(píng)估[D];天津醫(yī)科大學(xué);2017年
2 徐友康;智能化手功能訓(xùn)練系統(tǒng)對(duì)腦卒中患者手功能的影響[D];蚌埠醫(yī)學(xué)院;2015年
3 石素寧;品管圈管理方法在腦卒中偏癱患者功能鍛煉中的應(yīng)用效果分析[D];遼寧醫(yī)學(xué)院;2015年
4 袁青;懸吊運(yùn)動(dòng)療法對(duì)腦卒中偏癱患者膝過伸的療效觀察[D];成都中醫(yī)藥大學(xué);2015年
5 張明頊;高頻超聲評(píng)價(jià)腦卒中偏癱患者周圍神經(jīng)的形態(tài)學(xué)改變[D];山西醫(yī)科大學(xué);2016年
6 于明江·木拉提(Umut·Murat);滋陰通絡(luò)解痙法治療腦卒中后肢體痙攣性偏癱的臨床療效觀察[D];新疆醫(yī)科大學(xué);2016年
7 李楊;腦卒中患者延續(xù)性護(hù)理干預(yù)的效果評(píng)價(jià)[D];吉林大學(xué);2016年
8 劉麗玲;腦卒中偏癱患者步行時(shí)足底壓力中心的特點(diǎn)[D];安徽醫(yī)科大學(xué);2016年
9 惠寒青;腦卒中偏癱患者健側(cè)手食指擺動(dòng)頻率研究[D];上海體育學(xué)院;2016年
10 車楠;以醫(yī)院為基礎(chǔ)的腦卒中危險(xiǎn)因素、預(yù)后因素的病例—對(duì)照研究[D];第四軍醫(yī)大學(xué);2016年
,本文編號(hào):2195621
本文鏈接:http://sikaile.net/yixuelunwen/shenjingyixue/2195621.html